SciSparc与Neurothera Labs及Clearmind Medicine合作 推动抑郁症疗法专利申请

美股速递
Mar 16

SciSparc Ltd.宣布,其与Neurothera Labs及Clearmind Medicine的合作已取得重要进展,三方共同提交了一项针对抑郁症治疗方法的专利申请。这一合作旨在结合各方在神经科学和药物研发领域的专长,开发创新的治疗方案。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10